Cerenome CNSY
NASDAQ CNSY
$1.77 +0.04 (+2.30%)
As of: Oct 22, 2026 · 3:12 PM EDT

Cerenome (CNSY) Short-Term Debt repayments (2025 - 2026)

Updated

Cerenome's Short-Term Debt repayments came in at $672,000 for Q2 2026, down 38.9% from the prior quarter.

Analysis

Cerenome (CNSY) Short-Term Debt repayments (2025 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Cerenome reported Short-Term Debt repayments of $1.77 million; for FY2025, it was $3.29 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ST Debt Repayment (Qtr)
1 Eli Lilly 1,170.42 Bn 1,139.01 Bn 19.71 Bn -
2 Johnson & Johnson 648.22 Bn 568.08 Bn 17.30 Bn 6.63 Bn
3 AbbVie 504.43 Bn 477.54 Bn 12.70 Bn -
4 Merck 369.14 Bn 323.52 Bn 12.21 Bn -
5 Novartis Ag 303.29 Bn 267.28 Bn 11.24 Bn -
6 Astrazeneca 268.21 Bn 241.90 Bn 12.86 Bn -
7 Amgen 242.56 Bn 197.96 Bn 7.24 Bn -
8 Gilead Sciences 194.91 Bn 169.11 Bn 6.22 Bn -
9 Pfizer 173.28 Bn 119.92 Bn 10.94 Bn -
10 Cerenome 12.21 Mn -34.97 Mn - 672,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 672,000.00
Mar 31, 2026 1.10 Mn
Mar 31, 2025 3.29 Mn
API Access

Cerenome Short-Term Debt repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt-repayments&ticker=CNSY&period=max&api_key=YOUR_API_KEY